J. Thompson

A randomized controlled study of iron supplementation in patients treated with erythropoietin.

I. Macdougall, B. Tucker, Jane Thompson, 1996, Kidney international.

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Chronic Myeloid Leukemia, Version 2.2021

K. Gregory, Hema M Sundar, M. Deininger, 2020 .

Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow Transplantation

N. Callander, J. Essell, M. Snyder, 1998, Annals of Internal Medicine.

Candida-specific systemic cell-mediated immune reactivities in human immunodeficiency virus-positive persons with mucosal candidiasis.

J. Sobel, R. Swoboda, J. Cutright, 2001, The Journal of infectious diseases.

Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b.

M. Ratain, D. Golde, H. Golomb, 1988, Seminars in oncology.

Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.

M. Ratain, J. Vardiman, D. Golde, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia.

M. Ratain, D. Golde, H. Golomb, 1988, Journal of the National Cancer Institute.

Clinical, immunophenotypic and functional characterisation of T-cell leukaemia in six horses.

J. Kydd, K. Smith, A. Durham, 2007, Equine veterinary journal.

Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.

M. Ratain, J. Vardiman, D. Golde, 1991, Leukemia & lymphoma.

Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.

M. Ratain, D. Golde, H. Golomb, 1987, Seminars in oncology.

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

M. Ratain, R. Mick, H. Golomb, 1991, Leukemia & lymphoma.